Literature DB >> 6148165

Arginine infusion increases peripheral plasma somatostatin in man.

S Skare, K F Hanssen, V Kriz, P A Torjesen.   

Abstract

A somatostatin (SRIF) radioimmunoassay is described, using an antiserum raised in rabbit, reacting more with SRIF-14 than -28. Glass tubes were employed for the assay because our tracer, 125I 1-Tyr-SRIF, was adsorbed to plastic (23% non specific binding). Vycor extraction was used, and following Sephadex G-50 chromatography, the plasma extract showed two forms, coeluting with SRIF-28 and -14. Fifteen healthy subjects, eight women and seven men, 21-39 years old, received an infusion of arginine chloride (2.38 mmol/kg) for 20 min, or saline. An immediate rise in plasma SRIF from the mean basal level at 2 min was shown. Maximal value was 24.0 +/- 3.0 pmol/l (P less than 0.01) after 10 min followed by a rapid descent towards the basal level after the infusion. A temporal relationship was observed between the SRIF, insulin and glucagon responses following arginine infusion, while the GH levels increased only after the SRIF levels had declined, indicating an inhibition of GH. This is further supported by the high degree of correlation (r = 0.87) between SRIF- and GH increments. It is suggested that plasma SRIF measurement during arginine infusion gives an estimate of the pancreatic SRIF releasing capacity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148165     DOI: 10.1111/j.1365-2265.1984.tb03473.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  6 in total

1.  Rise in urea concentration after arginine hydrochloride infusion.

Authors:  A Pedrotti; O Grigoras; J P Guignard
Journal:  Arch Dis Child       Date:  1989-11       Impact factor: 3.791

Review 2.  Endogenous somatostatin and the gut.

Authors:  M R Lucey
Journal:  Gut       Date:  1986-04       Impact factor: 23.059

3.  Effects of chronic slow release-lanreotide treatment on insulin-like growth factor system and metabolic parameters in acromegalic patients.

Authors:  V Gasco; G Beccuti; F Marotta; N Prencipe; M Maccario; J Janssen; A J van der Lely; E Ghigo; S Grottoli
Journal:  J Endocrinol Invest       Date:  2011-05-31       Impact factor: 4.256

4.  Low dose orally administered arginine is able to enhance both basal and growth hormone-releasing hormone-induced growth hormone secretion in normal short children.

Authors:  J Bellone; E Bartolotta; G Cardinale; E Arvat; V Cherubini; G Aimaretti; M Maccario; M Mucci; F Camanni; E Ghigo
Journal:  J Endocrinol Invest       Date:  1993 Jul-Aug       Impact factor: 4.256

5.  Effect of calcitonin and calcitonin gene-related peptide on pancreatic functions in man.

Authors:  C Beglinger; E Koehler; W Born; J A Fischer; U Keller; L E Hanssen; K Gyr
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

6.  A Transcriptome-Led Exploration of Molecular Mechanisms Regulating Somatostatin-Producing D-Cells in the Gastric Epithelium.

Authors:  Alice Adriaenssens; Brian Yee Hong Lam; Lawrence Billing; Katie Skeffington; Sabine Sewing; Frank Reimann; Fiona Gribble
Journal:  Endocrinology       Date:  2015-08-04       Impact factor: 4.736

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.